Skip to main content

Peer Review reports

From: PRIMMO study protocol: a phase II study combining PD-1 blockade, radiation and immunomodulation to tackle cervical and uterine cancer

Original Submission
8 Mar 2019 Submitted Original manuscript
29 Mar 2019 Author responded Author comments - Sandra Tuyaerts
Resubmission - Version 2
29 Mar 2019 Submitted Manuscript version 2
29 Apr 2019 Author responded Author comments - Sandra Tuyaerts
Resubmission - Version 3
29 Apr 2019 Submitted Manuscript version 3
Publishing
3 May 2019 Editorially accepted
28 May 2019 Article published 10.1186/s12885-019-5676-3

You can find further information about peer review here.

Back to article page